| David A Maged, MD | |
|
3105 Limestone Rd, Ste 301, Wilmington, DE 19808-2147 | |
| (302) 633-1700 | |
| (302) 633-4418 |
| Full Name | David A Maged |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 36 Years |
| Location | 3105 Limestone Rd, Wilmington, Delaware |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124028808 | NPI | - | NPPES |
| 62101 | Medicaid | DE | |
| 115006I71 | Other | DE | MEDICARE PTAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | C10003054 (Delaware) | Primary |
| 207R00000X | Internal Medicine | C1-0003054 (Delaware) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Geriatric Medicine Consultants Pa | 0244492072 | 21 |
News Archive
Fewer than 10% of people who experience sudden cardiac arrest (SCA) outside of a hospital survive. Reoccurrence rates after an initial event are high, which is why current Canadian Cardiovascular Society, as well as other international guidelines, strongly recommend the use of implantable cardioverter defibrillators (ICDs) in selected patients who survive cardiac arrest.
In a report published in The Lancet, researchers say there is the potential to develop 20 new or improved vaccines over the next decade. They emphasize that funding is crucial - but so is trust and confidence in vaccines. It is said that AIDS and malaria vaccines as the most important areas for research. Authors further suggest that neglected tropical diseases, such as leprosy, should also be investigated.
Neogenix Oncology announced today that Dr. Luis Diaz of The Johns Hopkins University Hospital will present data from Ensituximab, the company's novel, therapeutic antibody to treat pancreatic and colorectal cancers. The presentation is scheduled at the American Society of Clinical Oncology (ASCO) 2011 Gastrointestinal Cancers Symposium to be held January 20-22, 2011 at the Moscone Center in San Francisco, CA, USA.
Scientists conducting the first comprehensive study of key immune system cells-;collected from West African Ebola survivors that kill Ebola infected cells have made a surprising discovery that provides important clues to developing effective vaccines against the infection.
The Indian drugmaker Natco Pharma "said Wednesday it has informed Pfizer Inc. that it wants to make and sell a low-cost generic version of the U.S. company's [drug] maraviroc for treating the HIV infection under a so-called 'compulsory license'," Dow Jones Newswires/Smart Money reports.
› Verified 7 days ago
| Entity Name | Geriatric Medicine Consultants Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598031643 PECOS PAC ID: 0244492072 Enrollment ID: O20120424000410 |
News Archive
Fewer than 10% of people who experience sudden cardiac arrest (SCA) outside of a hospital survive. Reoccurrence rates after an initial event are high, which is why current Canadian Cardiovascular Society, as well as other international guidelines, strongly recommend the use of implantable cardioverter defibrillators (ICDs) in selected patients who survive cardiac arrest.
In a report published in The Lancet, researchers say there is the potential to develop 20 new or improved vaccines over the next decade. They emphasize that funding is crucial - but so is trust and confidence in vaccines. It is said that AIDS and malaria vaccines as the most important areas for research. Authors further suggest that neglected tropical diseases, such as leprosy, should also be investigated.
Neogenix Oncology announced today that Dr. Luis Diaz of The Johns Hopkins University Hospital will present data from Ensituximab, the company's novel, therapeutic antibody to treat pancreatic and colorectal cancers. The presentation is scheduled at the American Society of Clinical Oncology (ASCO) 2011 Gastrointestinal Cancers Symposium to be held January 20-22, 2011 at the Moscone Center in San Francisco, CA, USA.
Scientists conducting the first comprehensive study of key immune system cells-;collected from West African Ebola survivors that kill Ebola infected cells have made a surprising discovery that provides important clues to developing effective vaccines against the infection.
The Indian drugmaker Natco Pharma "said Wednesday it has informed Pfizer Inc. that it wants to make and sell a low-cost generic version of the U.S. company's [drug] maraviroc for treating the HIV infection under a so-called 'compulsory license'," Dow Jones Newswires/Smart Money reports.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David A Maged, MD 3105 Limestone Rd, Ste 301, Wilmington, DE 19808-2147 Ph: (302) 633-1700 | David A Maged, MD 3105 Limestone Rd, Ste 301, Wilmington, DE 19808-2147 Ph: (302) 633-1700 |
News Archive
Fewer than 10% of people who experience sudden cardiac arrest (SCA) outside of a hospital survive. Reoccurrence rates after an initial event are high, which is why current Canadian Cardiovascular Society, as well as other international guidelines, strongly recommend the use of implantable cardioverter defibrillators (ICDs) in selected patients who survive cardiac arrest.
In a report published in The Lancet, researchers say there is the potential to develop 20 new or improved vaccines over the next decade. They emphasize that funding is crucial - but so is trust and confidence in vaccines. It is said that AIDS and malaria vaccines as the most important areas for research. Authors further suggest that neglected tropical diseases, such as leprosy, should also be investigated.
Neogenix Oncology announced today that Dr. Luis Diaz of The Johns Hopkins University Hospital will present data from Ensituximab, the company's novel, therapeutic antibody to treat pancreatic and colorectal cancers. The presentation is scheduled at the American Society of Clinical Oncology (ASCO) 2011 Gastrointestinal Cancers Symposium to be held January 20-22, 2011 at the Moscone Center in San Francisco, CA, USA.
Scientists conducting the first comprehensive study of key immune system cells-;collected from West African Ebola survivors that kill Ebola infected cells have made a surprising discovery that provides important clues to developing effective vaccines against the infection.
The Indian drugmaker Natco Pharma "said Wednesday it has informed Pfizer Inc. that it wants to make and sell a low-cost generic version of the U.S. company's [drug] maraviroc for treating the HIV infection under a so-called 'compulsory license'," Dow Jones Newswires/Smart Money reports.
› Verified 7 days ago
Dr. Shady Abdelbaki, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 501 W 14th St, Wilmington, DE 19801 Phone: 302-320-2490 Fax: 302-623-4395 | |
Terry L Horton, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 501 W 14th St, Room 5236, Wilmington, DE 19801 Phone: 302-428-4574 Fax: 302-428-2569 | |
Dr. Susan M Keith, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1601 Kirkwood Hwy, Wilmington, DE 19805 Phone: 302-633-5302 Fax: 302-633-5582 | |
Dr. Melissa D. Morgan-gouveia, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 501 W 14th St, Wilmington Hospital - Adult Medicine Office, Wilmington, DE 19801 Phone: 302-428-4411 Fax: 302-428-4667 | |
Dr. Alfonso Paul Ciarlo, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5311 Limestone Road, Suite 100, Wilmington, DE 19808 Phone: 302-234-2200 Fax: 302-234-2262 | |
Dr. Robert Anselmo Jakubowski, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 501 W 14th St Fl 6, Wilmington, DE 19801 Phone: 302-320-1300 Fax: 302-320-1373 | |
Dr. Brajesh Narayan Agarwal, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1601 Kirkwood Hwy, Medical Service (111), Wilmington, DE 19805 Phone: 302-633-5302 Fax: 302-633-5582 |